You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 2, February 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE SECOND ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, BOSTON, APRIL 19-20, 1982-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Third-Generation Cephalosporins for Polymicrobial Surgical Sepsis

H. Harlan Stone, MD; Priscilla R. Strom, MD; Timothy C. Fabian, MD; William E. Dunlop, MD

Arch Surg. 1983;118(2):193-200.


Abstract

• During 31 months of study, 808 patients with polymicrobial surgical infection were randomized for antibiotic therapy between a third-generation cephalosporin (moxalactam disodium [149], cefotaxime sodium [125], and cefoperazone sodium [141]) and the combination of gentamicin sulfate plus clindamycin (393). Results based on antibiotic therapy included the following: cure in 83% given cephalosporin, 73% with antibiotic combination; control but recurrent sepsis in 7% and 15%; and failure in 4% and 8%, respectively. Such data support the tenet that third-generation cephalosporins are at least equal, if not superior, to the combination of gentamicin plus clindamycin for treatment of polymicrobial surgical sepsis.

(Arch Surg 1983;118:193-200)



Author Affiliations

From the Department of Surgery, Emory University School of Medicine, Atlanta.


Footnotes

Accepted for publication Sept 7, 1982.

Read before the second annual meeting of the Surgical Infection Society, Boston, April 19, 1982.

Reprint requests to Department of Surgery, Emory University School of Medicine, 69 Butler St, Atlanta, GA 30303 (Dr Stone).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Moxalactam vs Tobramycin-Clindamycin: A Randomized Trial in Secondary Peritonitis
Stellato et al.
Arch Surg 1988;123:714-717.
ABSTRACT  

Prospective Study Comparing Imipenem-Cilastatin With Clindamycin and Gentamicin for the Treatment of Serious Surgical Infections
Hackford et al.
Arch Surg 1988;123:322-326.
ABSTRACT  

Treatment of Severe Intra-abdominal Sepsis and/or Necrotic Foci by an 'Open-Abdomen' Approach: Zipper and Zipper-Mesh Techniques
Garcia-Sabrido et al.
Arch Surg 1988;123:152-156.
ABSTRACT  

Burn Wound Sepsis
Hansbrough
J Intensive Care Med 1987;2:313-327.
ABSTRACT  

Design and Conduct of Antibiotic Trials: A Report of the Scientific Studies Committee of the Surgical Infection Society
Solomkin et al.
Arch Surg 1987;122:158-164.
ABSTRACT  

Single-Antibiotic Use for Penetrating Abdominal Trauma
Nelson et al.
Arch Surg 1986;121:153-156.
ABSTRACT  

Stratified Outcome Comparison of Clindamycin-Gentamicin vs Chloramphenicol-Gentamicin for Treatment of Intra-abdominal Sepsis
Lennard et al.
Arch Surg 1985;120:889-898.
ABSTRACT  

A Proposed Classification of Intra-abdominal Infections: Stratification of Etiology and Risk for Future Therapeutic Trials
Meakins et al.
Arch Surg 1984;119:1372-1378.
ABSTRACT  

Moxalactam: Evaluation of Clinical Bleeding in Patients With Abdominal Infection
Joehl et al.
Arch Surg 1983;118:1259-1261.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.